Intranasal Vaccination of Pups with Maternally Derived Antibodies with a Modified Live Canine Parvovirus
- 12 January 1994
- journal article
- Published by Wiley in Journal of Veterinary Medicine, Series B
- Vol. 41 (1-10) , 3-8
- https://doi.org/10.1111/j.1439-0450.1994.tb00199.x
Abstract
The modified live canine parvovirus (CPV) vaccine was used to vaccinate intranasally twenty‐five pups with maternal antibody. The vaccine was able to overcome the interference of maternal immunity in rates of 100 %, 72.7 % and 17.6 % in pups with haemagglutination inhibition antibody titre of 40, 80 and 160 respectively. © 1994 Blackwell Verlag GmbKeywords
This publication has 6 references indexed in Scilit:
- Response of pups with maternal derived antibody to modified-live canine parvovirus vaccineComparative Immunology, Microbiology and Infectious Diseases, 1992
- Performance of high titre attenuated canine parvovirus vaccine in pups with maternally derived antibodyPublished by Wiley ,1991
- Intranasal vaccination of pigs against Aujeszky’s disease: comparison with inactivated vaccines in pigs with low maternal antibody titresResearch in Veterinary Science, 1985
- Dog Response to Plaque Variant of Canine ParvovirusZentralblatt für Veterinärmedizin Reihe B, 1983
- Intranasal vaccination of pigs against Aujeszky's diseaseVeterinary Quarterly, 1982